Trials / Completed
CompletedNCT01785550
Neuromuscular Ultrasound in ALS
Ultrasonography in Amyotrophic Lateral Sclerosis as a Predictor of Disease Progression and Tool in Diagnosis: a Pilot Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- Duke University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Amyotrophic Lateral Sclerosis (ALS) is a progressive fatal neurodegenerative disease affecting motor neurons. Early diagnosis is essential for the success of clinical trials and objective biomarkers are needed for monitoring disease progression. Nerve and muscle ultrasound may provide this information. This study will collect pilot data to evaluate the value of muscle and nerve ultrasound to identify and monitor disease progression in ALS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Ultrasound of nerve and muscle | Ultrasound of 6 muscles and 2 nerves will be performed. |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2013-02-07
- Last updated
- 2015-03-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01785550. Inclusion in this directory is not an endorsement.